SARAH CHOW: Open Payments
NPI 1477249068 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 52 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $151 |
| Lilly USA, LLC | 6 | $112 |
| Novo Nordisk Inc | 5 | $93 |
| PFIZER INC. | 5 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Corcept Therapeutics | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Antares Pharma, Inc. | 3 | $46 |
| Amgen Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $27 |
Products named: Kerendia, Korlym, Ozempic, KISUNLA, VRAYLAR, UBRELVY, XYOSTED, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
